ERT Acquires APDM Wearable Technologies


Applied Clinical Trials

ERT has announced the acquisition of APDM Wearable Technologies, a provider of wearables and digital biomarkers. By integrating Patient Reported Outcomes data captured by ERT’s eCOA platform with data from APDM’s wearables and digital endpoints, trial sponsors gain insights as they develop new medical treatments for many therapies, including movement-related disorders. The integrated solution can be used to support in-clinic assessments as well as in trials conducted virtually. 

For more information, click here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.